49th Annual DIA Meeting, Boston
Taking place on June 23-27, this conference encompassed 250 sessions focusing on multiple industry disciplines, with over 22 tracks on pharmaceuticals, biotechnology, medical devices, and other related hot topics.
Key thought leaders from the life sciences industry provided up-to-date information on trends in the industry, such as big data, rare diseases, cooperation amongst regulators, and biologics. The meeting also provided an opportunity to network with CROs, institutional review boards, and regulatory agencies.
Read the full report from Beth Nuskey, Pharmaceutical Research Analyst for Thomson Reuters here.